JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online September 15, 2008
J Nucl Med 2008, doi:10.2967/jnumed.108.054361
© 2008 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.108.054361v1
49/10/1701    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kusmic, C.
Right arrow Articles by Sambuceti, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusmic, C.
Right arrow Articles by Sambuceti, G.


Whole-Body Evaluation of MIBG Tissue Extraction in a Mouse Model of Long-Lasting Type II Diabetes and Its Relationship with Norepinephrine Transport Protein Concentration

Claudia Kusmic 1*, Silvia Morbelli 2, Cecilia Marini 1, Marco Matteucci 3, Chiara Cappellini 3, Elena Pomposelli 2, Paolo Marzullo 1, Antonio L'Abbate 4, and Gianmario Sambuceti 2

1 Institute of Clinical Physiology CNR, Pisa, Italy
2 Department of Internal Medicine, Division of Nuclear Medicine, University of Genoa, Genova, Italy
3 Scuola Superiore Sant'Anna, Pisa, Italy
4 Institute of Clinical Physiology CNR, Pisa, ItalyScuola Superiore Sant'Anna, Pisa, Italy

* To whom correspondence should be addressed. E-mail: kusmic{at}ifc.cnr.it.


   Abstract

Accelerated cardiac washout of 123I-metaiodobenzylguanidine (MIBG), which is clinically used as an index of cardiac neuropathy in diabetes, is ascribed to decreased norepinephrine reuptake into synaptic vesicles. However, accelerated washout frequently contrasts with preserved early tracer uptake, whose significance remains undetermined. The aim of this study was to investigate in a mouse model of long-lasting type II diabetes whether the mismatch between MIBG early uptake and washout is the consequence of a more generalized disorder of the autonomic nervous system. Methods: Nine mice were given low doses of streptozotocin by intraperitoneal injection for 5 consecutive days. At 7 mo after streptozotocin, MIBG kinetics were evaluated by heart and liver time–activity curves and by tracer accumulation in the bladder. Data were compared with those obtained in 10 sham mice and correlated with the cardiac and hepatic tissue expression of norepinephrine transporter (NET) as assessed with a 3H-desipramine saturation binding assay. Results: In diabetic mice, myocardial and liver MIBG retention was reduced at 2 h and was associated with both increased tracer washout and reduced NET density. The rate of myocardial washout correlated with the degree of urinary MIBG excretion. Conclusion: The paradoxic observation of preserved early uptake associated with accelerated washout of MIBG in diabetes seems to be explained by a generalized disorder in NET function leading to reduced whole-body tracer removal from the blood and increased tracer availability for early myocardial uptake.

Key Words: type II diabetes, cardiac autonomic neuropathy, SPECT, radiobinding, mouse







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.